Category: Clinical Breakthroughs
-
Northwestern Investigators Explore COVID-19 Treatments
Working with large, multicenter teams, Northwestern clinician-scientists have examined treatments for blood clotting in critically ill patients with COVID-19, and explored therapies that could reduce disease progression and hospitalization.
-
Identifying Therapeutic Targets for B-cell Acute Lymphoblastic Leukemia
Northwestern Medicine investigators have identified a protein kinase called DYRK1A and its downstream substrates as potential therapeutic targets for treating pediatric patients with B-cell acute lymphoblastic leukemia.
-
Antibody Drug Improves Survival for Aggressive Breast Cancer
A new antibody drug demonstrated similar efficacy to currently available therapies to treat advanced ERBB2-positive breast cancer, according to a recent clinical trial.
-
New Anti-Obesity Medication Almost Twice as Effective as Most Currently Approved Weight-Loss Drugs
A new anti-obesity medication is almost twice as effective at helping individuals lose weight than current weight-loss drugs, according to a Northwestern Medicine study.
-
Multi-faceted Therapeutic Target for Metabolic Syndrome Discovered
Northwestern Medicine investigators have discovered a potential multi-faceted therapeutic target for preventing and treating the metabolic syndrome, according to a recent study.
-
Study Identifies New Potential Therapeutic Approach for Glioblastoma
Northwestern Medicine investigators have identified a potential combined targeted therapy approach for treating glioblastoma, according to a recent study published in the journal Scientific Reports.
-
Feinberg Investigators Explore COVID-19 Treatments and Impact
Feinberg investigators continue to investigate new treatments for COVID-19 and share insights on combating misinformation and mitigating the disease’s spread.
-
Drug for Advanced Parkinson’s Shows No Benefit
A drug that demonstrated neuroprotective effect and slowed disease progression in animal models of Parkinson’s disease showed no symptomatic benefit in patients with the neurodegenerative disorder, according to results from a clinical trial led by Northwestern Medicine investigators.
-
New Therapeutic Prospect for ALS
An experimental drug called ezogabine reduced spinal neuron excitability in patients with ALS, according to a recent study.
-
Novel Device Provides Continuous Monitoring of Skin, Prostheses
A multi-disciplinary team of investigators led by Northwestern scientists have developed a novel wireless device that can constantly monitor pressure and temperature between the patient’s skin and prosthesis, improving overall comfort and wellbeing.
